Showing results (61-70 of 212) with videos related to
Sort By:
Pageof 22
Plos One|March 9, 2013
Association of soluble Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) with central adiposity and low-density lipoprotein cholesterolGloria Brombo, Stefano Volpato, Paola Secchiero, et al.Plos One|February 15, 2013
In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndromeDiana Campioni, Giorgio Zauli, Stefania Gambetti, et al.Circulation|April 2, 2003
TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathwaysPaola Secchiero, Arianna Gonelli, Edvige Carnevale, et al.Journal of Cellular Physiology|September 10, 2008
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eyePaola Secchiero, Giuseppe Lamberti, Federica Corallini, et al.Diabetes|February 27, 2010
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetesGiorgio Zauli, Barbara Toffoli, Maria Grazia di Iasio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cellsPaola Secchiero, Rebecca Voltan, Maria Grazia di Iasio, et al.Biomed Research International|April 3, 2015
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complicationsPaolo Perri, Giorgio Zauli, Arianna Gonelli, et al.Journal of Cellular Physiology|July 7, 2011
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophagesPaola Secchiero, Erika Rimondi, Maria Grazia di Iasio, et al.International Journal of Molecular Sciences|October 23, 2021
Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative ImmunityAnnalisa Marcuzzi, Elisabetta Melloni, Giorgio Zauli, et al.Investigational New Drugs|October 19, 2010
Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cellsRaffaella Bosco, Marco Rabusin, Rebecca Voltan, et al.Pageof 22